Sugi Predict

Sugi Predict / Compounds / SCHEMBL10132638

SCHEMBL10132638

SCHEMBL10132638

COc1ccc(-c2c(OC)c(OC)cc3c2ccc2c4ccc5c(c4c(=O)n(C)c32)OCO5)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 3/20 0.47
▸ NQO2 P16083 3/20 0.47
▸ TDP1 Q9NUW8 1/20 0.40
▸ CYP3A4 P08684 4/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ EDNRA P25101 1/20 0.39
▸ SOST Q9BQB4 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ ACHE P22303 1/20 0.37
▸ EDNRB P24530 1/20 0.36
▸ PDE5A O76074 1/20 0.36
▸ TUBB4A P04350 2/20 0.36
▸ TUBB P07437 2/20 0.36
▸ TUBA3C P0DPH7 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL422412 0.92 CYP19A1 (0.47) CYP19A1NQO2TDP1CYP3A4LMNA
SCHEMBL10132618 0.92 CYP19A1 (0.48) CYP19A1NQO2TDP1CYP3A4LMNA
SCHEMBL10132870 0.79 CYP19A1 (0.56) CYP19A1NQO2TDP1ALDH1A1HPGD
SCHEMBL10132627 0.79 CYP19A1 (0.47) CYP19A1NQO2TDP1ALDH1A1HPGD
SCHEMBL10132722 0.77 CYP19A1 (0.49) CYP19A1NQO2TDP1ALDH1A1HPGD
SCHEMBL10163184 0.74 CYP19A1 (0.40) CYP19A1NQO2TDP1CYP3A4ALDH1A1
SCHEMBL10163291 0.74 ALDH1A1 (0.40) CYP19A1NQO2CYP3A4ALDH1A1MAPT
SCHEMBL10163171 0.74 CYP19A1 (0.41) CYP19A1NQO2CYP3A4ALDH1A1MAPT
SCHEMBL10163174 0.73 PDE3B (0.45) CYP19A1NQO2ALDH1A1HPGDHSD17B10
SCHEMBL10132646 0.73 CYP19A1 (0.40) CYP19A1NQO2TDP1CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 — — US disclosed
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 — — US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 — — US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 — — US disclosed
WO-2010083436-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-07-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH CYP19A1 596/4885NQO2 50/4885TDP1 1005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.